Antibiotic Use and the Emergence of Antibiotic Resistance in Clinical Settings, 2nd Edition
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Antibiotics Use and Antimicrobial Stewardship".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 28
Special Issue Editor
Interests: infectious diseases; antibiotic resistance; antibacterial stewardship
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce the second edition of the Special Issue, “Antibiotic Use and the Emergence of Antibiotic Resistance in Clinical Settings”.
In the realm of healthcare, the role of antibiotics in combating infectious diseases has been transformative. However, we are becoming increasingly aware that the emergence and development of antibiotic resistance threatens the very foundation of our medical practices. The relationship between antibiotic use and the development of resistance is a critical issue, demanding our immediate attention.
Following the success of the first edition, we are publishing this second edition to further examine this issue and broaden the scope of discussion. Our goal is to assemble a collection of research and insights that delve into the multifaceted relationship between antibiotic usage and the ever-evolving landscape of resistance.
This Special Issue welcomes original research articles and reviews. Research areas may include (but are not limited to) the following: the rational use of antibiotics in clinical infections, the impact of antibiotic consumption on resistance patterns, and the mechanisms underlying the development of resistance.
Dr. Aleksandra Barac
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antibiotic use
- antibiotic resistance
- clinical settings
- clinical infections
- mechanisms underlying the development of resistance
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
